Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 4,801 | 5,544 | 2,104 | 0 | 3,377 |
| Operating Income | -4,801 | -5,544 | -2,104 | N/A | -3,377 |
| Pre-tax Income | -4,801 | -5,544 | -2,104 | 0 | -3,377 |
| Income Tax | N/A | -1 | 0 | N/A | N/A |
| Net Income Continuous | -4,801 | -5,543 | -2,104 | N/A | -3,377 |
| Net Income | $-4,801 | $-5,545 | $-2,104 | $N/A | $-3,377 |
| EPS Basic Total Ops | -0.13 | -0.15 | -0.06 | N/A | -0.09 |
| EPS Basic Continuous Ops | -0.13 | -0.15 | -0.06 | N/A | -0.09 |
| EPS Diluted Total Ops | -0.13 | -0.15 | -0.06 | N/A | -0.09 |
| EPS Diluted Continuous Ops | -0.13 | -0.15 | -0.06 | N/A | -0.09 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.15 | -0.06 | N/A | -0.09 |
| EBITDA(a) | $-4,801 | $-5,544 | $-2,104 | $N/A | $-3,377 |